Pharmacological studies leading to the identification of hyperforin as a CNS-active component of Hypericum perforatum

被引：0
|
作者：
Nöldner, M [1 ]
Chatterjee, SS [1 ]
Erdelmeier, C [1 ]
机构：
[1] Dr Willmar Schwabe GmbH & Co, Res Labs, D-76209 Karlsruhe, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P5146
引用
收藏
页码：R495 / R495
页数：1
相关论文
共 17 条
  • [1] Pharmacological studies on Hypericum perforatum fractions and constituents
    Khan, Arif-ullah
    Gilani, Anwarul-Hassan
    Najeeb-ur-Rehman
    PHARMACEUTICAL BIOLOGY, 2011, 49 (01) : 46 - 56
  • [2] Pharmacological studies of an indigenous CNS-active drug delphinium denudatum wall. In view of its role in morphine addiction
    Rahman, SZ
    Khan, RA
    Kumar, A
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 95 - 95
  • [3] Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources
    McClatchey, Will C.
    Mahady, Gail B.
    Bennett, Bradley C.
    Shiels, Laura
    Savo, Valentina
    PHARMACOLOGY & THERAPEUTICS, 2009, 123 (02) : 239 - 254
  • [4] NEW DESIGN FOR SCREENING OF CNS-ACTIVE DRUGS IN MICE - MULTI-DIMENSIONAL OBSERVATION PROCEDURE AND STUDY OF PHARMACOLOGICAL INTERACTIONS
    MORPURGO, C
    ARZNEIMITTEL-FORSCHUNG, 1971, 21 (11): : 1727 - +
  • [5] Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate
    Eichenbaum, G.
    Zhou, J.
    Kelley, M. F.
    Roosen, W.
    Costa-Giomi, P.
    Louden, C.
    Di Prospero, N. A.
    Pandina, G.
    Singh, J. B.
    Ford, L.
    Moyer, J. A.
    Nork, T. M.
    Hoeve, J. N. Ver
    Aguirre, G. D.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 69 (02) : 187 - 200
  • [6] Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by hpyericin, an active component of Hypericum perforatum
    Kang, BY
    Chung, SW
    Kim, TS
    PLANTA MEDICA, 2001, 67 (04) : 364 - 366
  • [7] CNS-active drugs in aging population at high risk of cerebrovascular events: Evidence from preclinical and clinical studies
    Zhao, Chuan-Sheng
    Hartikainen, Sirpa
    Schallert, Timothy
    Sivenius, Juham
    Jolkkonen, Jukka
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (01): : 56 - 71
  • [8] Identification of rigidified CNS-active NK1 receptor antagonists and development of a detailed pharmacophore model.
    Albert, JS
    Ohnmacht, CJ
    Bernstein, PR
    Rumsey, WL
    Aharony, D
    Russell, DJ
    Shen, LH
    Dedinas, RF
    Russell, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U57 - U58
  • [9] THE SLEEP EEG AND NOCTURNAL HORMONAL SECRETION STUDIES ON CHANGES DURING THE COURSE OF DEPRESSION AND ON EFFECTS OF CNS-ACTIVE DRUGS
    STEIGER, A
    VONBARDELEBEN, U
    GULDNER, J
    LAUER, C
    ROTHE, B
    HOLSBOER, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1993, 17 (01): : 125 - 137
  • [10] Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): In vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models
    Fiebich, Bernd L.
    Knoerle, Rainer
    Appel, Kurt
    Kammler, Thomas
    Weiss, Gabriele
    FITOTERAPIA, 2011, 82 (03) : 474 - 480
12